信息搜索
信息关键字：药
  

共有5342条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265] [266] [267] [268]

·普利制药：已经获批的药物品种目前正在放量2018-10-7 16:51:53
·【高管面对面直播】普利制药：走特色发展道路打造仿制药国际竞争力2018-10-7 16:31:02
·嘉林药业澄清：不合格药品均非本公司生产2018-10-4 17:53:38
·嘉林药业澄清：不合格药品均非本公司生产2018-10-4 17:41:06
·乐普医疗参股公司旗下企业PD-1创新型单抗药物已进入II期临床试验2018-10-1 19:15:34
·今年诺贝尔生理学或医学奖揭晓！国内药企早已布局涉及这些上市公司2018-10-1 19:02:57
·华海回应遭欧美进口禁令沙坦类药物超百亿市场或大震荡2018-10-1 14:52:32
·九洲药业股东质押2160万股占比2.68%2018-9-30 15:36:21
·九洲药业股东质押1870万股占比2.32%2018-9-30 15:32:24
·华海药业回应遭欧美进口禁令：仅限于川南生产基地2018-9-30 11:31:58
·财通证券：康弘药业买入评级2018-9-30 10:04:14
·医药生物创新驱动成长研发投入排序与市值完全匹配2018-9-30 9:47:15
·美国FDA对华海药业原料药及成品药发出进口禁令2018-9-30 9:15:02
·医药生物全球前沿周报：从新型疫苗看给药路径2018-9-30 8:19:29
·图解|212家上市医药公司数据淘金：谁的黄金时代谁的至暗时刻2018-9-29 21:23:46
·金健米业拟转让药业子公司挂牌价格“1元起”2018-9-29 18:48:59
·医药股持续反弹医药板块仍是中长期值得重点关注品种2018-9-29 17:08:48
·20多省份药价降幅超15%部分医用耗材价格降幅高达92%2018-9-29 16:31:08
·普利制药股东质押345万股占比25.56%2018-9-29 16:27:24
·控股子公司拟在香港上市复星医药迎来“双喜临门”2018-9-29 15:49:54

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] [261] [262] [263] [264] [265] [266] [267] [268]